SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: Rudy Saucillo who wrote (1519)10/26/1998 10:25:00 AM
From: Jason Chesshir  Respond to of 2173
 
Thanks Rudy<eom>



To: Rudy Saucillo who wrote (1519)11/20/1998 9:57:00 AM
From: Abuckatatime  Read Replies (1) | Respond to of 2173
 
This may be old and redundant news and not relevant at this point but FWIW:

June article in Diabetes Care on Pramlintide in Type 2s
journal.diabetes.org

Sept. Canadian Journal of Diabetes Care as reprinted on Medscape. Modulation of nutrient intake by amylin and GLP-1
medscape.com